Search or

𝛼SK

ENTITY

Celltrion Inc (068270 KS)

637

Analysis

Health Care • South Korea

Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment

more

Refresh

Exchange Announcement • 19 Nov 2025 15:10

Material Business Matters Related to Investment Decisions(Signing of a Platform Technology Access and License Agreement with TRIOAR, Inc)

Exchange Announcement • 19 Nov 2025 15:10

Future Business or Management Plans (Fair Disclosure)

Exchange Announcement • 19 Nov 2025 14:20

Material Business Matters Related to Investment Decisions(í¸ë¦¬ì¤ì´ç¤¾ì íë«í¼ ê¸°ì ì¤ì ë° ë¼ì´ì ì¤ ê³ì½ ì²´ê²°)

Exchange Announcement • 19 Nov 2025 09:51

Future Business or Management Plans (Fair Disclosure)

Exchange Announcement • 04 Nov 2025 15:48

[Revised] Report on Business Performance according to Consolidated Financial Statements (Fair Disclosure)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x